Filing Details

Accession Number:
0000899866-14-000207
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-09-26 17:52:52
Reporting Period:
2014-09-26
Filing Date:
2014-09-26
Accepted Time:
2014-09-26 17:52:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899866 Alexion Pharmaceuticals Inc ALXN Pharmaceutical Preparations (2834) 133648318
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1231949 Leonard Bell C/O Alexion Pharmaceuticals Inc
352 Knotter Drive
Cheshire CT 06410
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Per Share Disposition 2014-09-26 40,825 $164.83 968,061 No 4 S Direct
Common Stock, Par Value $.0001 Per Share Disposition 2014-09-26 14,837 $165.43 953,224 No 4 S Direct
Common Stock, Par Value $.0001 Per Share Disposition 2014-09-26 4,338 $166.72 948,886 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
  2. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $164.22 - $165.22. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
  3. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $165.22 - $166.22. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
  4. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $166.27 - $167.27. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.